Benjamin F. Edwards & Company’s CollPlant Biotechnologies CLGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $197K | Sell |
39,760
-10,690
| -21% | -$53K | ﹤0.01% | 913 |
|
|
2024
Q1 | $272K | Buy |
50,450
+300
| +0.6% | +$1.62K | ﹤0.01% | 820 |
|
|
2023
Q4 | $320K | Buy |
50,150
+5,100
| +11% | +$32.5K | 0.01% | 733 |
|
|
2023
Q3 | $254K | Sell |
45,050
-4,160
| -8% | -$23.5K | 0.01% | 670 |
|
|
2023
Q2 | $399K | Sell |
49,210
-16,701
| -25% | -$135K | 0.02% | 567 |
|
|
2023
Q1 | $463K | Buy |
65,911
+4,861
| +8% | +$34.1K | 0.02% | 503 |
|
|
2022
Q4 | $510K | Sell |
61,050
-4,360
| -7% | -$36.4K | 0.02% | 462 |
|
|
2022
Q3 | $447K | Sell |
65,410
-6,400
| -9% | -$43.7K | 0.02% | 459 |
|
|
2022
Q2 | $585K | Sell |
71,810
-3,460
| -5% | -$28.2K | 0.03% | 419 |
|
|
2022
Q1 | $861K | Buy |
75,270
+16,576
| +28% | +$190K | 0.04% | 368 |
|
|
2021
Q4 | $960K | Buy |
58,694
+1,050
| +2% | +$17.2K | 0.04% | 351 |
|
|
2021
Q3 | $973K | Sell |
57,644
-6,990
| -11% | -$118K | 0.05% | 345 |
|
|
2021
Q2 | $1.37M | Sell |
64,634
-5,186
| -7% | -$110K | 0.07% | 282 |
|
|
2021
Q1 | $938K | Buy |
69,820
+55,300
| +381% | +$743K | 0.05% | 343 |
|
|
2020
Q4 | $156K | Buy |
+14,520
| New | +$156K | 0.01% | 702 |
|